The appointments come as the Gothenburg-based company prepares to split into two standalone companies in 2027, both owned by Patricia Industries, as announced on September 16, 2026. Fredrik Wallefors is expected to become CEO of Mölnlycke Surgical if and when the split and the relevant consultations with employee representatives have been completed. Guillaume Joucla will remain acting CEO of Mölnlycke Health Care until the end of 2026.

Related article

Mölnlycke to split into two standalone companies

The company is to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company, provisionally named ‘Mölnlycke Surgical’, while Wound Care and Antiseptics continue as Mölnlycke.

“Anders Andersson and Fredrik Wallefors both have the experience and drive needed to successfully lead our businesses forward, with a continued strong focus on patients, healthcare professionals, and customers,” says Karl-Henrik Sundström, Chair of the Board, Mölnlycke.

“We are pleased that two internal candidates have been appointed as Mölnlycke’s new leaders. Anders and Fredrik are highly experienced leaders with in-depth knowledge of their respective businesses and a clear ambition to drive continued profitable growth,” says Thomas Kidane, Co-Head, Patricia Industries.